ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 628,80
0,76%
Dow Jones
38 834,86
0,15%
DAX
18 131,97
0,32%
Brent Oil
84,785
0,00%
Bitcoin
65 609,24
0,72%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Ironwood Pharmaceuticals Inc (IRWD)

  7. Ironwood Pharmaceuticals Inc (IRWD) Actualités

IRWD Ironwood Pharmaceuticals Inc

5,71
0,01 (0,18%)
19 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Ironwood Pharmaceuticals Inc IRWD NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,01 0,18% 5,71 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
5,75 5,61 5,785 5,71 5,70
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
12/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:57EDGAR2Form 144 - Report of proposed sale of securities
07/6/202419:35EDGAR2Form 144 - Report of proposed sale of securities
06/6/202421:57EDGAR2Form 144 - Report of proposed sale of securities
30/5/202422:01BWIronwood Pharmaceuticals to Participate in the Jefferies..
22/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202412:00BWIronwood Late-Breaker Oral Presentation at Digestive Disease..
20/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:11EDGAR2Form 144 - Report of proposed sale of securities
17/5/202422:08EDGAR2Form 144 - Report of proposed sale of securities
17/5/202422:07EDGAR2Form 144 - Report of proposed sale of securities
17/5/202422:04EDGAR2Form 144 - Report of proposed sale of securities
09/5/202422:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:09EDGAR2Form 8-K - Current report
09/5/202413:00BWIronwood Pharmaceuticals Reports First Quarter 2024 Results
06/5/202422:01BWIronwood Pharmaceuticals to Participate in The Citizens JMP..
01/5/202413:30BWIronwood Pharmaceuticals to Present New Data on Once-Weekly..
25/4/202422:01BWIronwood Pharmaceuticals to Host First Quarter 2024 Investor..
28/3/202412:30BWIronwood Pharmaceuticals Announces Positive Results from its..
08/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202412:00BWIronwood Pharmaceuticals Announces Positive Topline Results..
23/2/202413:30BWIronwood Pharmaceuticals to Present Four Abstracts at the..
15/2/202413:04EDGAR2Form 8-K - Current report
15/2/202413:00BWIronwood Pharmaceuticals Reports Fourth Quarter and Full..
15/2/202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:13EDGAR2Form 144 - Report of proposed sale of securities
09/2/202422:11EDGAR2Form 144 - Report of proposed sale of securities
09/2/202422:09EDGAR2Form 144 - Report of proposed sale of securities
09/2/202422:05EDGAR2Form 144 - Report of proposed sale of securities
01/2/202422:01BWIronwood Pharmaceuticals to Host Fourth Quarter and Full..
19/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202401:00BWIronwood Announces Publication in The Lancet..
08/1/202412:05EDGAR2Form 8-K - Current report
08/1/202412:00BWIronwood Pharmaceuticals Maintains FY 2023 Financial..
03/1/202422:01BWIronwood Pharmaceuticals to Present at the 42nd Annual J.P...

Dernières Valeurs Consultées

NASDAQ
IRWD
Ironwood Pharmaceuticals
NASDAQ
CSLMU
CSLM Acquisition
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés